X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (271) 271
ophthalmology (257) 257
glaucoma (188) 188
administration, topical (161) 161
male (161) 161
female (158) 158
index medicus (150) 150
middle aged (138) 138
aged (132) 132
topical antiglaucoma medication (116) 116
open-angle glaucoma (98) 98
glaucoma - drug therapy (83) 83
adult (78) 78
glaucoma, open-angle - drug therapy (78) 78
intraocular pressure - drug effects (78) 78
trabeculectomy (73) 73
aged, 80 and over (65) 65
ophthalmic solutions (63) 63
intraocular pressure (61) 61
benzalkonium chloride (57) 57
intraocular-pressure (55) 55
latanoprost (55) 55
antihypertensive agents - administration & dosage (53) 53
treatment outcome (53) 53
timolol (50) 50
animals (47) 47
surgery (47) 47
drugs (43) 43
glaucoma - surgery (42) 42
filtration surgery (40) 40
eye diseases (39) 39
prospective studies (39) 39
conjunctiva (37) 37
ocular hypertension - drug therapy (37) 37
ocular surface (37) 37
conjunctiva - drug effects (36) 36
pharmacology & pharmacy (36) 36
antihypertensive agents - adverse effects (35) 35
follow-up studies (35) 35
ocular hypertension (35) 35
dry eye (34) 34
genetic structures (34) 34
retrospective studies (34) 34
adrenergic beta-antagonists - adverse effects (33) 33
antihypertensive agents - therapeutic use (33) 33
drug therapy, combination (33) 33
ophthalmic drugs (33) 33
sense organs (32) 32
conjunctiva - pathology (30) 30
in-vitro (30) 30
ophthalmic solutions - administration & dosage (30) 30
preservatives (30) 30
adrenergic beta-antagonists - administration & dosage (29) 29
therapy (29) 29
timolol - administration & dosage (29) 29
drug therapy (28) 28
adrenergic beta-antagonists - therapeutic use (27) 27
filtering surgery (26) 26
travoprost (26) 26
care and treatment (25) 25
glaucoma - physiopathology (25) 25
prevalence (25) 25
glaucoma, open-angle - surgery (24) 24
hypertension (24) 24
preservatives, pharmaceutical - adverse effects (24) 24
prostaglandins f, synthetic - administration & dosage (24) 24
eye (23) 23
glaucoma, open-angle - physiopathology (23) 23
ophthalmic solutions - adverse effects (23) 23
risk factors (23) 23
rabbits (22) 22
tonometry, ocular (22) 22
analysis (21) 21
double-blind method (21) 21
topical antiglaucoma medications (21) 21
cornea - drug effects (20) 20
mitomycin-c (20) 20
research (20) 20
timolol - therapeutic use (20) 20
adolescent (19) 19
cloprostenol - analogs & derivatives (19) 19
long-term (19) 19
medicine & public health (19) 19
cornea (18) 18
efficacy (18) 18
ocular surface disease (18) 18
risk-factors (18) 18
carbonic anhydrase inhibitors - administration & dosage (17) 17
disease (17) 17
health aspects (17) 17
inflammation (17) 17
patients (17) 17
timolol - adverse effects (17) 17
cell count (16) 16
dosage and administration (16) 16
intraocular pressure - physiology (16) 16
prostaglandins (16) 16
studies (16) 16
toxicity (16) 16
trabeculectomy - methods (16) 16
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (336) 336
French (14) 14
German (8) 8
Korean (6) 6
Polish (3) 3
Romanian (2) 2
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Drugs & Aging, ISSN 1170-229X, 4/2011, Volume 28, Issue 4, pp. 267 - 282
Glaucoma affects millions of people around the world. With the baby boom generation aging, the number of people affected by primary open-angle glaucoma in the... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Glaucoma | Carbonic-anhydrase-inhibitors | treatment | Apraclonidine | Dorzolamide | Cholinergic-receptor- agonists | Brimonidine | Beta-adrenergic-receptor-antagonists | Pilocarpine | Latanoprost | Alpha-adrenergic-receptor-agonists | Elderly | therapeutic use | Bimatoprost | Brinzolamide | Travoprost | ALLERGIC CONTACT-DERMATITIS | CARBONIC-ANHYDRASE INHIBITOR | OPEN-ANGLE GLAUCOMA | BETA-BLOCKING-AGENTS | INTRAOCULAR-PRESSURE ELEVATIONS | MULTICENTER CLINICAL-TRIAL | DORZOLAMIDE EYE DROPS | PHARMACOLOGY & PHARMACY | ARGON-LASER TRABECULOPLASTY | AQUEOUS BARRIER PERMEABILITY | BENZALKONIUM CHLORIDE | GERIATRICS & GERONTOLOGY | Prostaglandins - pharmacology | Cholinergic Agents - pharmacology | Humans | Eyelids - drug effects | Adrenergic beta-Agonists - pharmacology | Treatment Outcome | Carbonic Anhydrase Inhibitors - pharmacology | Glaucoma, Open-Angle - drug therapy | Eye Diseases - chemically induced | Cornea - drug effects | Conjunctiva - drug effects | Adrenergic alpha-Agonists - pharmacology | Eye - drug effects | Patient Compliance | Administration, Topical | Eye Diseases - pathology | Drugs | Complications and side effects | Ophthalmic drugs | Adverse and side effects | Diagnosis | Research | Drug therapy | Risk factors | Index Medicus
Journal Article
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2000, Volume 22, Issue 2, pp. 167 - 208
Much experience has been gained with the use of older classes of antiglaucoma agents—topical beta-adrenergic-receptor antagonists, nonselective... 
alpha 2-adrenergic-receptor agonists | beta-adrenergic-receptor antagonists | prostaglandin analogues | carbonic anhydrase inhibitors | glaucoma | adverse effects | cholinergic agents | Glaucoma | Beta-adrenergic-receptor antagonists | Carbonic anhydrase inhibitors | Adverse effects | Cholinergic agents | Prostaglandin analogues | ELEVATED INTRAOCULAR-PRESSURE | ALLERGIC CONTACT-DERMATITIS | LIPOPROTEIN CHOLESTEROL LEVEL | OPHTHALMIC BETA-BLOCKERS | TOPICAL TIMOLOL MALEATE | OPEN-ANGLE GLAUCOMA | MULTICENTER CLINICAL-TRIAL | CYSTOID MACULAR EDEMA | PHARMACOLOGY & PHARMACY | alpha-adrenergic-receptor agonists | OCULAR HYPOTENSIVE EFFICACY | CARBONIC-ANHYDRASE INHIBITORS | Humans | Drug Tolerance | Carbonic Anhydrase Inhibitors - administration & dosage | Glaucoma - drug therapy | Prostaglandins F, Synthetic - adverse effects | Prostaglandins F, Synthetic - therapeutic use | Adrenergic alpha-Agonists - therapeutic use | Adrenergic alpha-Agonists - administration & dosage | Adrenergic alpha-Agonists - adverse effects | Adrenergic beta-Antagonists - adverse effects | Carbonic Anhydrase Inhibitors - adverse effects | Administration, Topical | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - therapeutic use | Carbonic Anhydrase Inhibitors - therapeutic use | Safety and security measures | Heterocyclic compounds | Ophthalmic drugs | Prostanoids
Journal Article
Ophthalmic Research, ISSN 0030-3747, 09/2012, Volume 48, Issue 3, pp. 139 - 145
Purpose: To investigate the effects of topical application of cyclosporine or vitamin A on the ocular surface during the concurrent administration of... 
Original Paper | Adverse ocular surface change | Topical vitamin A | Multiple antiglaucoma drugs | Topical cyclosporine | LONG-TERM | OPHTHALMIC EMULSION | BLINDNESS | TRIAL | OPEN-ANGLE GLAUCOMA | RETINOIC ACID | THERAPY | DISEASE | OPHTHALMOLOGY | IMPRESSION CYTOLOGY | DRY EYE SYNDROME
Journal Article
Australian and New Zealand Journal of Psychiatry, ISSN 0004-8674, 10/2001, Volume 35, Issue 5, pp. 569 - 571
Journal Article
PLOS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2
Introduction To demonstrate that preoperative treatment for 28 days with topical dorzolamide/timolol is non-inferior (Delta = 4 mm Hg) to oral acetazolamide... 
SURGERY | SUCCESS | MULTIDISCIPLINARY SCIENCES | DRUGS | CONJUNCTIVA | TOPICAL ANTIGLAUCOMA MEDICATION
Journal Article